Published Papers & Misc - TAKAHASHI Hidehiko

Division display  21 - 40 of about 89 ／  All the affair displays >>

  1. Ishida T, Nakamura Y, Tanaka SC, Mitsuyama Y, Yokoyama S, Shinzato H, Itai E, Okada G, Kobayashi Y, Kawashima T, Miyata J, Yoshihara Y, Takahashi H, Morita S, Kawakami S, Abe O, Okada N, Kunimatsu A, Yamashita A, Yamashita O, Imamizu H, Morimoto J, Okamoto Y, Murai T, Kasai K, Kawato M, Koike S. Aberrant Large-Scale Network Interactions Across Psychiatric Disorders Revealed by Large-Sample Multi-Site Resting-State Functional Magnetic Resonance Imaging Datasets. Schizophrenia bulletin. 2023.03; 49 (4): 933-943. ( PubMed, DOI )

  2. Nakamura Y, Ishida T, Tanaka SC, Mitsuyama Y, Yokoyama S, Shinzato H, Itai E, Okada G, Kobayashi Y, Kawashima T, Miyata J, Yoshihara Y, Takahashi H, Aoki R, Nakamura M, Ota H, Itahashi T, Morita S, Kawakami S, Abe O, Okada N, Kunimatsu A, Yamashita A, Yamashita O, Imamizu H, Morimoto J, Okamoto Y, Murai T, Hashimoto RI, Kasai K, Kawato M, Koike S. Distinctive alterations in the mesocorticolimbic circuits in various psychiatric disorders. Psychiatry and clinical neurosciences. 2023.03; 77 (6): 345-354. ( PubMed, DOI )

  3. Miyashita T, Takagi S, Ishii S, Kobayashi N, Jitoku D, Genichi S, Takahashi H. Moderation effect of the eveningness chronotype on the relationship between ADHD tendency and Internet addiction. Psychiatry and clinical neurosciences. 2023.03; 77 (6): 366-367. ( PubMed, DOI )

  4. Itahashi T, Yamashita A, Takahara Y, Yahata N, Aoki YY, Fujino J, Yoshihara Y, Nakamura M, Aoki R, Ohta H, Sakai Y, Takamura M, Ichikawa N, Okada G, Okada N, Kasai K, Tanaka SC, Imamizu H, Kato N, Okamoto Y, Takahashi H, Kawato M, Yamashita O, Hashimoto RI. Generalizable neuromarker for autism spectrum disorder across imaging sites and developmental stages: A multi-site study. bioRxiv : the preprint server for biology. 2023.03; ( PubMed, DOI )

  5. Takahiro Kawata, Genichi Sugihara, Yoichi Kakibuchi, Midori Tomitaka, Miho Miyajima, Eisuke Matsushima, Takashi Takeuchi, Hidehiko Takahashi. Attention-deficit hyperactivity symptoms and risk of alcohol use relapse. Neuropsychopharmacology reports. 2023.03; 43 (1): 103-111. ( PubMed, DOI )

  6. Shiwaku H, Katayama S, Gao M, Kondo K, Nakano Y, Motokawa Y, Toyoda S, Yoshida F, Hori H, Kubota T, Ishikawa K, Kunugi H, Ikegaya Y, Okazawa H, Takahashi H. Analyzing schizophrenia-related phenotypes in mice caused by autoantibodies against NRXN1α in schizophrenia. Brain, behavior, and immunity. 2023.03; 111 32-45. ( PubMed, DOI )

  7. Sami H, Tei S, Takahashi H, Fujino J. Association of cognitive flexibility with neural activation during the theory of mind processing. Behavioural brain research. 2023.02; 443 114332. ( PubMed, DOI )

  8. Takahashi H, Kato T. The start of a new journey of Psychiatry and Clinical Neurosciences. Psychiatry and clinical neurosciences. 2023.01; 77 (1): 1. ( PubMed, DOI )

  9. Kanda K, Tei S, Takahashi H, Fujino J. Neural basis underlying the sense of coherence in medical professionals revealed by the fractional amplitude of low-frequency fluctuations. PloS one. 2023; 18 (6): e0288042. ( PubMed, DOI )

  10. Ishii S, Takagi S, Kobayashi N, Jitoku D, Sugihara G, Takahashi H. Hyperfocus symptom and internet addiction in individuals with attention-deficit/hyperactivity disorder trait. Frontiers in psychiatry. 2023; 14 1127777. ( PubMed, DOI )

  11. Matsumoto Y, Nishida S, Hayashi R, Son S, Murakami A, Yoshikawa N, Ito H, Oishi N, Masuda N, Murai T, Friston K, Nishimoto S, Takahashi H. Disorganization of Semantic Brain Networks in Schizophrenia Revealed by fMRI. Schizophrenia bulletin. 2022.12; 49 (2): 498-506. ( PubMed, DOI )

  12. Yawata T, Takagi S, Tamura T, Sugihara G, Takahashi H. Psychosis treatment in a patient with Parkinsonian type multiple system atrophy using modified electroconvulsive therapy: a case report. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society. 2022.12; 23 (2): 364-367. ( PubMed, DOI )

  13. Watanabe R, Kim Y, Kuruma H, Takahashi H. Imitation encourages empathic capacity toward other individuals with physical disabilities. NeuroImage. 2022.12; 264 119710. ( PubMed, DOI )

  14. Kubota M, Takahata K, Matsuoka K, Sano Y, Yamamoto Y, Tagai K, Tarumi R, Suzuki H, Kurose S, Nakajima S, Shiwaku H, Seki C, Kawamura K, Zhang MR, Takahashi H, Takado Y, Higuchi M. Positron Emission Tomography Assessments of Phosphodiesterase 10A in Patients With Schizophrenia. Schizophrenia bulletin. 2022.12; 49 (3): 688-696. ( PubMed, DOI )

  15. Tabata K, Miyashita M, Yamasaki S, Toriumi K, Ando S, Suzuki K, Endo K, Morimoto Y, Tomita Y, Yamaguchi S, Usami S, Itokawa M, Hiraiwa-Hasegawa M, Takahashi H, Kasai K, Nishida A, Arai M. Hair zinc levels and psychosis risk among adolescents. Schizophrenia (Heidelberg, Germany). 2022.11; 8 (1): 107. ( PubMed, DOI )

  16. Takahashi Y, Yamamoto T, Oyama J, Sugihara G, Shirai Y, Tao S, Takigawa M, Sato H, Sasaki M, Hirakawa A, Takahashi H, Goya M, Sasano T. Increase in Cerebral Blood Flow After Catheter Ablation of Atrial Fibrillation. JACC. Clinical electrophysiology. 2022.11; 8 (11): 1369-1377. ( PubMed, DOI )

  17. Tamura T, Sugihara G, Okita K, Mukai Y, Matsuda H, Shiwaku H, Takagi S, Daisaki H, Tateishi U, Takahashi H. Dopamine dysfunction in depression: application of texture analysis to dopamine transporter single-photon emission computed tomography imaging. Translational psychiatry. 2022.08; 12 (1): 309. ( PubMed, DOI )

  18. Takagi S, Yamashiro K, Sugihara G, Matsuura M, Takahashi H. Hippocampal calcification and its effects on cognitive function and symptoms in dementia. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society. 2022.07; 22 (4): 427-432. ( PubMed, DOI )

  19. Takeuchi H, Yahata N, Lisi G, Tsurumi K, Yoshihara Y, Kawada R, Murao T, Mizuta H, Yokomoto T, Miyagi T, Nakagami Y, Yoshioka T, Yoshimoto J, Kawato M, Murai T, Morimoto J, Takahashi H. Development of a classifier for gambling disorder based on functional connections between brain regions. Psychiatry and clinical neurosciences. 2022.06; 76 (6): 260-267. ( PubMed, DOI )

  20. Shiwaku H, Katayama S, Kondo K, Nakano Y, Tanaka H, Yoshioka Y, Fujita K, Tamaki H, Takebayashi H, Terasaki O, Nagase Y, Nagase T, Kubota T, Ishikawa K, Okazawa H, Takahashi H. Autoantibodies against NCAM1 from patients with schizophrenia cause schizophrenia-related behavior and changes in synapses in mice. Cell reports. Medicine. 2022.04; 3 (4): 100597. ( PubMed, DOI )

< PREV - NEXT >

To the head of this page.▲